Phoreus Biotechnology, Inc.
Phoreus Biotech is a pioneering life science company specializing in the development of next-generation peptide nanocarriers for drug, vaccine, and therapeutic delivery. With a focus on innovative nanotechnology platforms like BAPC, CAPC, and APC, the company aims to revolutionize treatment efficacy, stability, and safety across human, animal, and environmental health sectors. Their mission is to advance targeted, safe, and effective delivery systems that overcome limitations of traditional carriers, enabling new possibilities in medicine, agriculture, and biotechnology.
Industries
Nr. of Employees
small (1-50)
Phoreus Biotechnology, Inc.
22201 W. Innovation Drive, Olathe, Kansas 66061-1304
Products
Peptide-based transfection reagent kit
A peptide nanocarrier transfection kit supplied with reagent components and a protocol for forming peptide/nucleic acid complexes and transfecting diverse cell lines; guidance provided for N/P ratio optimization and complex formation.
Peptide nanocarrier platform portfolio
Set of peptide-based nanocarrier platforms including branched amphipathic peptide capsules, corralling amphipathic peptide colloids, and amphipathic peptide capsules designed for encapsulation and targeted delivery of nucleic acids, proteins, small molecules and agricultural actives.
Peptide-based transfection reagent kit
A peptide nanocarrier transfection kit supplied with reagent components and a protocol for forming peptide/nucleic acid complexes and transfecting diverse cell lines; guidance provided for N/P ratio optimization and complex formation.
Peptide nanocarrier platform portfolio
Set of peptide-based nanocarrier platforms including branched amphipathic peptide capsules, corralling amphipathic peptide colloids, and amphipathic peptide capsules designed for encapsulation and targeted delivery of nucleic acids, proteins, small molecules and agricultural actives.
Services
Joint development projects with academic and industry partners to identify targets, optimize carrier formulations, and advance translational research for human, animal and plant applications.
Provision of peptide-based transfection reagent kits and stepwise protocols including N/P ratio guidance and complexation procedures for cell transfection experiments.
Analytical and biological testing services including in vitro transfection assays, cytotoxicity testing, biodistribution studies, and stability/toxicology evaluations to support product development.
Joint development projects with academic and industry partners to identify targets, optimize carrier formulations, and advance translational research for human, animal and plant applications.
Provision of peptide-based transfection reagent kits and stepwise protocols including N/P ratio guidance and complexation procedures for cell transfection experiments.
Analytical and biological testing services including in vitro transfection assays, cytotoxicity testing, biodistribution studies, and stability/toxicology evaluations to support product development.
Expertise Areas
- Peptide nanoparticle development
- Nucleic acid delivery and transfection
- Formulation for shelf-stable mRNA
- Biopesticide (RNAi) delivery
Key Technologies
- Peptide-based nanoparticle design
- Self-assembling branched amphipathic peptide capsules
- Peptide colloid encapsulation
- Nucleic acid delivery (siRNA, dsRNA, mRNA, plasmid, CRISPR components)
News & Updates
Phoreus Biotech was awarded at the virtual event for its nanocarrier technology in veterinary vaccines, emphasizing stability and efficacy improvements.
Studies demonstrate that BAPC nanocarriers can enable shelf-stable mRNA formulations, reducing logistical challenges.
Leadership change aimed at accelerating clinical applications and industry partnerships.
An overview of biopesticides derived from natural materials and their role in sustainable agriculture.
Details on the self-assembling properties and advantages of Branched Amphipathic Peptide Capsules (BAPC).
Explores the use of BAPC in delivering RNAi biopesticides for pest control.
Phoreus Biotech was awarded at the virtual event for its nanocarrier technology in veterinary vaccines, emphasizing stability and efficacy improvements.
Studies demonstrate that BAPC nanocarriers can enable shelf-stable mRNA formulations, reducing logistical challenges.
Leadership change aimed at accelerating clinical applications and industry partnerships.
An overview of biopesticides derived from natural materials and their role in sustainable agriculture.
Details on the self-assembling properties and advantages of Branched Amphipathic Peptide Capsules (BAPC).
Explores the use of BAPC in delivering RNAi biopesticides for pest control.